Genetic Factors in Toxicology: Implications for Toxicological Screening

References

• Al-Dabbagh S. G., Idle J. R., Smith R. L. Animal modelling of human polymorphic drug oxidation—the metabolism of debrisoquine and phenacetin in rat inbred strains. J. Pharm. Pharmacol. 1981; 33: 161
   PubMed Web of Science ®Google Scholar
• Altman D. G. Comparability of randomised groups. Statistician 1985; 34: 125
   Google Scholar
• Arcos J. C., Argus M. F., Wolf G. Chemical Induction of Cancer. Academic Press, London 1968
   Google Scholar
• Bakke O. M., Wardell W. M., Lasagna L. Drug discontinuations in the United Kingdom and United States, 1964 to 1983: issues of safety. Clin. Pharmacol. Ther. 1984; 35: 559
   PubMed Web of Science ®Google Scholar
• Black D. Forward. Iatrogenic Disease, P. F. D'Arcy, J. P. Griffin. Oxford University Press, Oxford 1979
   Google Scholar
• Bonner J. J., Tyan M. L. Glucocorticoid-induced cleft palate genes in chromosome 17: genetic linkage and mapping analysis. Immunogenetics 1984; 20: 169
   PubMed Web of Science ®Google Scholar
• Buttner D., Hackbarth H., Wollnik F., Berggreve H. Blood pressure in rats: a comparison of a multifactorial experimental design to measurements in an outbred stock. Lab. Anim. 1984; 18: 110
   PubMedGoogle Scholar
• Campbell J. S., Mikhale N. Z., Napke E. Evidence and appraisal for adverse reactions to drugs and other preparations used in hospital practice. Methods Achiev. Exp. Pathol. 1981; 10: 221
   PubMedGoogle Scholar
• Clark D. W. J. Genetically determined variability in acetylation and oxidation. Drugs 1985; 29: 342
   PubMed Web of Science ®Google Scholar
• Principles for Evaluating Chemicals in the Environment. Committee for the Working Conference on Principles of Protocols for Evaluating Chemicals in the Environment. 1975. National Academy of Sciences, Washington, D.C. 1975
   Google Scholar
• Crabbe J. C., Jarvik L. F., Liston E. H., Jenden D. J. Behavioral responses to amphetamines in identical twins. Acta Genet. Med. Gemellol. 1983; 32: 139
   PubMedGoogle Scholar
• D'Arcy P. F., Griffin J. P. Iatrogenic Diseases, 2nd ed. Oxford University Press, Oxford 1979
   Google Scholar
• Deitrich R. A. Genetic aspects of increase in rat liver aldehyde dehydrogenase induced by phenobarbital. Science 1971; 173: 334
   PubMed Web of Science ®Google Scholar
• Devonshire H. W., Kong I., Cooper M., Sloan T. P., Idle J. R., Smith R. L. The contribution of genetically determined oxidation status to inter-individual variation in phenacetin disposition. Br. J. Clin. Pharmacol. 1983; 16: 157
   PubMed Web of Science ®Google Scholar
• Diwan B. A. Strain-dependent teratogenic effects of 1-ethyl-1-nitrosourea in inbred strains of mice. Cancer Res. 1974; 34: 151
   PubMed Web of Science ®Google Scholar
• Eichelbaum M. Defective oxidation of drugs: pharmacokinetic and therapeutic implications. Clin. Pharmacokinet. 1982; 7: 1
   PubMed Web of Science ®Google Scholar
• Evans D. A. P. Genetic factors in adverse reactions to drugs and chemicals. PAR, Pseudo-Allergic Reactions. Involvement of Drugs and Chemicals, Vol. 1, P. Dukor, P. Kallos, H. D. Schlumberger, G. B. West. S. Karger, Basel 1980; 1.
   Google Scholar
• Evans D. A. P., Eze L. C., Whibley E. J. The association of the slow acetylator phenotype with bladder cancer. J. Med. Genet. 1983; 20: 330
   PubMed Web of Science ®Google Scholar
• Evans D. A. P., Harmer D., Downham D. Y., Whibley E. J., Idle J. R., Ritchie J., Smith R. L. The genetic control of sparteine and debrisoquine metabolism in man with new methods for analysing bimodal distributions. J. Med. Genet. 1983; 20: 321
   PubMed Web of Science ®Google Scholar
• Falconer D. S., Bloom J. L. A genetic study of induced lung tumours in mice. Br. J. Cancer 1962; 16: 665
   PubMed Web of Science ®Google Scholar
• Festing M. F. W. A case for using inbred strains of laboratory animals in evaluating the safety of drugs. Food and Cosmet. Toxicol. 1975; 13: 369
   PubMedGoogle Scholar
• Festing M. F. W. Inbred Strains in Biomedical Research. Macmillan Press, London 1979
   Google Scholar
• Festing M. F. W. Properties of inbred strains and outbred stocks, with special reference to toxicity testing. J. Toxicol. Environ. Health 1979; 5: 53
   PubMed Web of Science ®Google Scholar
• Festing M. F. W. Inbred strains and the factorial experimental design in toxicological screening. Proc. of the 7th ICLAS Symp. Gustav Fischer Verlag, Stuttgart 1980; 59.
   Google Scholar
• Festing M. F. W. The choice of animals in toxicological screening: inbred strains and the factorial experimental design. Acta Zool. Pathol. Antverp. 1980; 75: 117
   Google Scholar
• Festing M. F. W. The use of inbred strains in toxicological screening as a means of reducing the number of animals used. Animal Experimentation: Improvements and Alternatives, N. Marsh, S. Haywood. Frame, Nottingham 1985; 69.
   Google Scholar
• Festing M. F. W., Eydman T. Genetic variation in the response of mouse peritoneal macro-phages to xenobiotics in-vitro. I. General methodology and response to some model compounds. Toxicology In Vitro, in press
   Google Scholar
• Flaks A. The susceptibility of various strains of neonatal mice to the carcinogenic effect of 9,10-dimethyl-1,2-benzanthracine. Eur. J. Cancer 1968; 4: 579
   Google Scholar
• Food and Drug Advisory Committee on Protocols for Safety Evaluation. Panel on carcinogenesis report on cancer testing in the safety evaluation of food additives and pesticides. Toxicol. Appl. Pharmacol. 1971; 20: 419
   PubMed Web of Science ®Google Scholar
• Godowicz B., Pawlus M. Inheritance of sensitivity to cadmium-induced testicular damage in mice. Folia Histochem. Cytochem. 1979; 17: 267
   PubMedGoogle Scholar
• Greaves J. H., Ayres P. B. Unifactorial inheritance of warfarin resistance inRattus norvegicus from Denmark. Genet. Res. 1977; 29: 215
   PubMedGoogle Scholar
• Green M. C., Azar C. A., Maren T. H. Strain differences in susceptibility to the teratogenic effect of acetazolamide in mice. Teratology 1973; 8: 143
   PubMedGoogle Scholar
• Genetic Variants and Strains of the Laboratory Mouse, M. C. Green. Gustav Fischer Verlag, Stuttgart 1979
   Google Scholar
• Grisham J. W., Smith G. J. Predictive and mechanistic evaluation of toxic responses in mammalian cell culture systems. Pharmacol. Rev. 1984; 36: 151
   PubMedGoogle Scholar
• Gruneberg H. The Genetics of the Mouse, 2nd ed. Martinus-Nijhof, The Hague 1952
   Google Scholar
• Hanna J. M. Metabolic responses of the Chinese, Japanese and Europeans to alcohol. Alcoholism Clin. Exp. Res. 1978; 2: 89
   PubMed Web of Science ®Google Scholar
• Haseman J. K., Hoel D. G. Statistical design of toxicity assays: role of genetic structure of test animal population. J. Toxicol. Environ. Health 1979; 5: 89
   PubMed Web of Science ®Google Scholar
• Heston W. E. Genetic aspects of experimental animals in cancer research. Gann Monogr. 1968; 5
   Google Scholar
• Hill R. N., Clemens T. L., Liu D. K., Vesell E. S. Genetic control of chloroform toxicity in mice. Science 1975; 190: 159
   PubMed Web of Science ®Google Scholar
• Idle J. R., Smith R. L. Polymorphisms of oxidation at carbon centers of drugs and their clinical significance. Drug Metab. Rev. 1979; 9: 301
   PubMed Web of Science ®Google Scholar
• Idle J. R., Ritchie J. C. Probing genetically variable carcinogen metabolism using drugs. Human Carcinogenesis, C. C. Harris, H. N. Autrup. Academic Press, New York 1983; 857.
   Google Scholar
• Idle J. R., Smith R. L. Inter-ethnic differences in the metabolic disposition of drugs and toxic substances. Toxicology in the Tropics, R. L. Smith, E. A. Babaunmi. Taylor and Francis, London 1980; 238.
   Google Scholar
• James I. M. Volunteer studies and human pharmacology—phase I. The Principles and Practice of Clinical Trials, C. S. Good. Churchill Livingstone, Edinburgh 1976; 17.
   Google Scholar
• Jurima M., Inaba T., Kadar D., Kalow W. Genetic polymorphism of mephenytoinp(4′)-hydroxylation: difference between Orientals and Caucasians. Br. J. Clin. Pharmacol. 1985; 19: 483
   PubMed Web of Science ®Google Scholar
• Kalow W. Pharmacogenetics. W. B. Saunders, Philadelphia 1962
   Google Scholar
• Kalow W. Ethnic differences in drug metabolism. Clin. Pharmacokinet. 1982; 7: 373
   PubMed Web of Science ®Google Scholar
• Kalow W. Pharmacoanthropology: outline, problems, and the natural case histories. Fed. Proc. Fed. Am. Soc. Exp. Biol. 1984; 43: 2314
   PubMedGoogle Scholar
• Kalow W. Pharmacoanthropology: drug metabolism. Fed. Proc. Fed. Am. Soc. Exp. Biol. 1984; 43: 2326
   PubMedGoogle Scholar
• Kalter H. Interplay of intrinsic and extrinsic factors. Teratology, J. G. Wilson, J. Warkany. University of Chicago Press, Chicago 1965
   Google Scholar
• Kalter H. Dose-response studies with genetically homogeneous lines of mice as a teratology testing and reassessment procedure. Teratology 1981; 24: 79
   PubMedGoogle Scholar
• Kouri R. E., Salerno R. A., Whitmire C. E. Relationships between arylhydrocarbon hydroxylase inducibility and sensitivity to chemically induced subcutaneous sarcomas in various strains of mice. J. Natl. Cancer Inst. 1973; 50: 363
   PubMed Web of Science ®Google Scholar
• La Du B. N., Eckerson W. The polymorphic paroxanase/arylesterase isozymes of human serum. Fed. Proc. Fed. Am. Soc. Exp. Biol. 1984; 43: 2338
   PubMedGoogle Scholar
• Lader M., Kendell R., Kasriel J. The genetic contribution to unwanted drug effects. Clin. Pharmacol. Ther. 1974; 16: 343
   PubMed Web of Science ®Google Scholar
• Lovell D. P. Variation in pentobarbitone sleeping time in mice. I. Strain and sex differences. Lab. Anim. 1986; 20: 85
   PubMed Web of Science ®Google Scholar
• Lowrance W. W. Of Acceptable Risk. Harvard University Press, Cambridge, Mass. 1976
   Google Scholar
• Ludwig J., Axelsen R. Drug effects on the liver. Dig. Dis. Sci. 1983; 28: 651
   PubMed Web of Science ®Google Scholar
• Lush I. E. Mouse pharmacogenetics. Biology of the House Mouse, R. J. Berry. Symp. Zoology Society of London, Academic Press, London 1981; 517
   Google Scholar
• Lush I. E., Andrews K. M. Genetic variation between mice in their metabolism of coumarin and its derivatives. Genet. Res. (Cambridge) 1978; 31: 177
   PubMed Web of Science ®Google Scholar
• Lush I. E., Arnold C. J. High coumarin 7-hydroxylase activity does not protect mice against warfarin. Heredity 1975; 35: 279
   PubMed Web of Science ®Google Scholar
• Lynch H. T., Reich J. W. Diethylstilbestrol, genetics, teratogenesis, and tumor spectrum in humans. Med. Hypotheses 1985; 16: 315
   PubMed Web of Science ®Google Scholar
• MacRae K. D. Statistical aspects of trial design. The Principles and Practice of Clinical Trials, C. S. Good. Churchill Livingstone, Edinburgh 1976; 87.
   Google Scholar
• Martin N. G., Oakeshott J. G., Gibson J. B., Starmer G. A., Perl J., Wilks A. V. A twin study of psychomotor and physiological responses to an acute dose of alcohol. Behav. Genet. 1985; 15: 305
   PubMed Web of Science ®Google Scholar
• McKusick V. A. Mendelian Inheritance in Man, 6th ed. The Johns Hopkins University Press, Baltimore 1983
   Google Scholar
• Meier H. Experimental Pharmacogenetics. Academic Press, New York 1963
   Google Scholar
• Nebert D. W. Human genetic variation in enzyme detoxication. Enzymatic Basis of Detoxication, Vol. 1, W. B. Jakoby. Academic Press, New York 1980; 25.
   Google Scholar
• Nebert D. W., Felton J. S., Robinson J. R. Genetic differences in susceptibility to cancer and toxicity caused by environmental chemicals. Developmental and Genetic Aspects of Drug and Environmental Toxicity, W. A. Duncan, L. Julou, M. Kramer. Excerpta Medica, Amsterdam 1975; 82.
   Google Scholar
• Office of Technology Assessment. The Role of Genetic Testing in the Prevention of Occupational Disease, Congressional Board of the 98th Congress. OTA, Washington, D.C. 1983
   Google Scholar
• Omenn G. S. Advances in genetics and immunology: the role of basic research to prevention of occupational diseases. Arch. Environ. Health 1984; 39: 173
   PubMed Web of Science ®Google Scholar
• Popper K. R. Objective Knowledge. Oxford University Press, Oxford 1972
   Google Scholar
• Rice C. M., O'Brien S. J. Genetic variance of laboratory outbred Swiss mice. Nature (London) 1980; 283: 157
   PubMed Web of Science ®Google Scholar
• Roe Daphne A. Therapeutic significance of drug-nutrient interactions in the elderly. Pharma. Rev. 1984; 36: 109
   Google Scholar
• Sanitato J. J., Burke M. J. Atropine toxicity in identical twins. Ann. Ophthalmol. 1983; 15: 380
   PubMedGoogle Scholar
• Scott J., Poffenbarger P. L. Pharmacogenetics of tolbutamide metabolism in humans. Diabetes 1979; 28: 41
   PubMed Web of Science ®Google Scholar
• Seidegard J., Pero R. W. The hereditary transmission of high glutathione transferase activity towards trans-stilbene oxide in human mononuclear leukocytes. Hum. Genet. 1985; 69: 66
   PubMed Web of Science ®Google Scholar
• Shellabarger C. J., Stone J. P., Holtzman S. Rat differences in mammary tumor induction with estrogen and neutron irradiation. J. Natl. Cancer Inst. 1978; 61: 1505
   PubMedGoogle Scholar
• Simmons D. L., Lally P. A., Kasper C. B. Chromosomal assignments of genes coding for components of the mixed-function oxidase system in mice. J. Biol. Chem. 1985; 260: 515
   PubMed Web of Science ®Google Scholar
• Smith R. B. Clinical trials—Phases II, III, and IV. The Principles and Practice of Clinical Trials, C. S. Good. Churchill Livingstone, Edinburgh 1976; 23.
   Google Scholar
• Spielberg S. P. In vitro assessment of pharmacogenetic susceptibility to toxic drug metabolites in humans. Fed. Proc. Fed. Am. Soc. Exp. Biol. 1984; 43: 2308
   PubMedGoogle Scholar
• Strickler S., Miller M. M., Andermann E., Dansky L. V., Seni M-H., Spielberg S. P. Genetic predisposition to phenytoin-induced birth defects. Lancet 1985; 5: 746
   Google Scholar
• Strong L. C. Differences in response among mice of fifteen inbred strains to the subcutaneous injection of methylcholanthrene. Yale J. Biol. Med. 1952; 25: 34
   PubMed Web of Science ®Google Scholar
• Taylor B. A. Linkage of the cadmium resistance locus to loci on mouse chromosome 12. J. Hered. 1976; 67: 389
   PubMed Web of Science ®Google Scholar
• Taylor B. A. Genetic analysis of susceptibility to isoniazid-induced seizures in mice. Genetics 1976; 83: 373
   PubMed Web of Science ®Google Scholar
• Venning G. R. Identification of adverse reactions to new drugs. I. What have been the important adverse reactions since thalidomide. Br. Med. J. 1983; 286: 199
   PubMedGoogle Scholar
• Vesell E. S. Factors altering the responsiveness of mice to hexobarbital. Pharmacology 1968; 1: 81
   PubMed Web of Science ®Google Scholar
• Vesell E. S. Pharmacogenetic determinants of drug toxicity. Developmental and Genetic Aspects of Drug and Environmental Toxicity, Vol. 16, W. A. M. Duncan, L. Julou, M. Kramer. Excerpta Medica, Amsterdam 1975; 71.
   Google Scholar
• Vesell E. S. Pharmacogenetic determinants of drug toxicity. Developmental and Genetic Aspects of Drug and Environmental Toxicity, Vol. 16, W. A. M. Duncan, L. Julou, M. Kramer. Excerpta Medica, Amsterdam 1975; 71.
   Google Scholar
• Vesell E. S. New directions in pharmacogenetics. Fed. Proc. Fed. Am. Soc. Exp. Biol. 1984; 43: 2319
   PubMedGoogle Scholar
• Vesell E. S., Penno M. B. A new polymorphism of hepatic drug oxidation in humans: family studies of antipyrine metabolites. Fed. Proc. Fed. Am. Soc. Exp. Biol. 1984; 43: 2342
   PubMedGoogle Scholar
• Vesell E. S., Penno M. B. Assessment of methods to identify sources of interindividual pharmacokinetic variations. Clin. Pharmacokinet. 1983; 8: 378
   PubMed Web of Science ®Google Scholar
• Vesell E. S., Page J. G., Passananti G. T. Genetic and environmental factors affecting ethanol metabolism in man. Clin. Pharmacol. Ther. 1971; 12: 192
   PubMed Web of Science ®Google Scholar
• Wallace M. E., MacSwiney F. J. A major gene controlling warfarin-resistance in the house mouse. J. Hyg. (Cambridge) 1976; 76: 173
   PubMedGoogle Scholar
• Weber W. W. Acetylation pharmacogenetics: experimental models for human toxicity. Fed. Proc. Fed. Am. Soc. Exp. Biol. 1984; 43: 2332
   PubMedGoogle Scholar
• Weinshilboum R. M. Human pharmacogenetics of methyl conjugation. Fed. Proc. Fed. Am. Soc. Exp. Biol. 1984; 43: 2303
   PubMedGoogle Scholar
• Whitlock J. P. The regulation of cytochrome P-450 gene expression. Annu. Rev. Pharmacol. Toxicol. 1986; 26: 333
   PubMed Web of Science ®Google Scholar
• Wolf C. R. Cytochrome P-450s: polymorphic multigene families involved in carcinogen activation. Trends Genet. 1986; 2: 209
   Web of Science ®Google Scholar
• Wood A. M., Taylor B. A. Genetic regulation of coumarin hydroxylase activity in mice. Evidence for single locus control on chromosome 7. J. Biol. Chem. 1979; 254: 5647
   PubMed Web of Science ®Google Scholar
• Zidek Z., Janku I. Genetic approach to quantitative toxic reactions. Developmental and Genetic Aspects of Drug and Environmental Toxicity, Vol. 16, W. A. Duncan, L. Julou, M. Kramer. Excerpta Medica, Amsterdam 1975; 96.
   Google Scholar